Clear language saves time and money – also in the pharmaceutical industry

From the perspective of a person working in the pharmaceutical industry, the benefit/risk relationship of clear language is solely positive as benefits are numerous yet there are no adverse effects at all.


Multilingual Nordic packages against availability problems

Multilingual Nordic packages are an important option for making medicines available in as many countries in the Nordic region as possible.


A new digital era is dawning for PBB services

Last autumn, DRA was invited to participate in a pilot project concerned with real-life testing of the Pharmaceuticals Pricing Board’s electronic services.

1 2 3